Efficacy of MGI 114 (6-hydroxymethylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograft

By Kelner M.J.   McMorris T.C.   Estes L.   Samson K.M.   Bagnell R.D.   Taetle R.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 908-913

Elsevier

Access to resources Recommend Favorite

In vivo antitumour efficacy of MGI-114 (6-hydroxymethylacylfulvene, HMAF) in various human tumour xenograft models including several lung and gastric tumours

By Sato Y.   Kashimoto S.   MacDonald J.R.   Nakano K.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1419-1428

Elsevier

Access to resources Recommend Favorite

Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft

By Bigioni M.  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 621-629

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced efficacy of combination therapy with adenoassociated virus-delivered pigment epithelium-derived factor and cisplatin in a mouse model of Lewis lung carcinoma

By                  

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2069-2076

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC)

By Langer C.J.   McAleer C.A.   Bonjo C.A.   Litwin S.   Millenson M.   Kosierowski R.   Blankstein K.   Alexander R.   Ozols R.F.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 183-193

Elsevier

Access to resources Recommend Favorite